Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy.

By A. Trotti, R. Byhardt, J. Stetz, C. Gwede, B. Corn, K. Fu, L. Gunderson, B. McCormick, M. Morris, T. Rich and 2 more. International Journal of Radiation Oncology, Biology, Physics, 2000

822 citations recorded by the source corpus.

Subfields: Safety Research, Social Psychology

View Paper: https://www.semanticscholar.org/paper/ca4e573f523e7f2637370ea03b6bc668512211df

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. W. Schröder
2. S. Costa
3. U. Nitz
4. M. Warm
5. T. Bauknecht
6. W. Meier
7. V. Möbus
8. G. Emons

Citations in the corpus

• A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer. (2003, methodology): “Adverse events and toxicities were graded by study investigators according to the National Cancer Institute (NCI) Common Toxicity Criteria (CTC) (15, 16 ).”
• Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis (2004, neutral): “Radiotherapy to the head and neck or to the pelvis or abdomen is associated with an increased incidence of Grade 3 and Grade 4 oral or GI mucositis, respectively, often exceeding 50% of patients.(20) Among patients undergoing head and neck radiotherapy, pain and decreased oral function may persist l”